HMPV Virus: Amid recent reports of an outbreak of Human Metapneumovirus (HMPV) in China, The Directorate General of Health Services (DGHS) Atul Goyal said on Friday that HMPV (human metapneumovirus) is a normal respiratory problem that causes the common cold. He also stated that so far no case of this virus has been reported in India yet.
#WATCH | #HMPV (human metapneumovirus) is a normal respiratory problem that causes the common cold. No case of HMPV virus has been reported in India yet: DGHS, Dr. Atul Goyal on the #HMPVVirus @MoHFW_INDIA @NCDCMoHFW https://t.co/E8PSit1Tzl pic.twitter.com/JBHn7vUGUp
— DD News (@DDNewslive) January 3, 2025
The National Centre for Disease Control (NCDC) under the Union Health Ministry is closely monitoring respiratory and seasonal influenza cases in the country and is in touch with international agencies, news agency ANI reported, citing official sources. “We will continue to monitor the situation closely, validate information, and update accordingly,” ANI quoted official sources as saying.
“The data from December 16-22 indicates a recent rise in acute respiratory infections, including seasonal influenza, rhinovirus, respiratory syncytial virus (RSV), and human metapneumovirus (HMPV), however, the overall scale and intensity of respiratory infectious diseases in China this year is lower than last year. A seasonal increase in respiratory pathogens is expected in the northern hemisphere, particularly during the winter period,” ANI sources said after an update from WPRO.
Dr. Arjun Dang, CEO, Dr. Dangs Lab, said that the Human Metapneumovirus (HMPV) outbreak in China highlights the need for heightened surveillance and early detection mechanisms to curb its spread.
“The resurgence of Human Metapneumovirus (HMPV) underscores the ever-evolving challenges posed by respiratory viruses, particularly in high-density populations. HMPV, a relatively underrecognized pathogen, has been a silent contributor to seasonal respiratory illnesses globally. At Dr. Dang’s Lab, we have routinely reported cases of HMPV during flu seasons, particularly in vulnerable populations such as young children, older adults, and those with compromised immune systems. This outbreak in China highlights the need for heightened surveillance and early detection mechanisms to curb its spread,” Dr Arjun Dang said.
Dr. Dang said that HMPV usually shows symptoms similar to other respiratory viruses and if the outbreak isn’t quickly controlled, it can put a lot of strain on the healthcare system. “HMPV commonly manifests with symptoms akin to other respiratory viruses, including fever, cough, nasal congestion, shortness of breath, and wheezing. Severe cases can lead to bronchiolitis or pneumonia, particularly in high-risk groups. The burden on the healthcare system can be significant if the outbreak is not swiftly contained,” Dr Arjun Dang added.
Dr. Dang underlined that “Polymerase Chain Reaction (PCR) testing remains the gold standard for diagnosing HMPV.” Dang said there is no specific antiviral treatment for HMPV, so prevention is the cornerstone of controlling its spread. He added that simple measures such as washing hands regularly, covering mouth while coughing, and avoiding close contact with sick individuals can help reduce its spread.
“Unfortunately, there is no specific antiviral treatment for HMPV, and management is primarily supportive, focusing on hydration, fever control, and oxygen therapy in severe cases. Therefore, prevention becomes the cornerstone of controlling its spread. Simple yet effective measures such as frequent hand hygiene, respiratory etiquette (covering coughs and sneezes), and avoiding close contact with symptomatic individuals can significantly mitigate transmission. Government authorities must ensure robust public awareness campaigns emphasizing these preventive strategies,” Dr. Dang said.
(With ANI Inputs)
